Generics to Impact North American Oral Solid Drug Dosage Excipients Market

Blockbuster drugs worth $73,850 million are expected to lose patent protection in the United States between 2009 and 2017, resulting in an influx of generic manufacturers. This briefing will investigate the increase in volume of drugs and the relative increase in excipients volume.

Why you should attend?

1. Understand the different types of excipients used in solid drug dosage forms, their price, current market size and future market scenario.

2. Learn key unmet needs and success factors for oral solid drug dosage excipients.

3. Identify the drivers and restraints of the market.

Jan 23 2014

46 mins